Subscribe To
ENVB / Enveric Biosciences to Participate in Upcoming Investor Conferences in February 2022
Content Topics
Genuine
Parts
Company
0iux
Enveric
Biosciences
Participate
Upcoming
Investor
Conferences
February
Stock
ENVB
ENVB News
By InvestorPlace
May 18, 2023
Why Is Enveric Biosciences (ENVB) Stock Up 120% Today?
Enveric Biosciences (NASDAQ: ENVB ) stock is enlivened amid an otherwise soft early afternoon session on Wall Street, delivering triple-digit percenta more_horizontal
By Business Wire
February 22, 2023
Enveric Biosciences to Present at the Gravitas Securities Inc. 6th Annual Growth Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the d more_horizontal
By Business Wire
February 1, 2023
Enveric Biosciences to Present at the BIO CEO & Investor Conference
CAMBRIDGE, Mass.--( BUSINESS WIRE )--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the more_horizontal
By Business Wire
December 21, 2022
Enveric Biosciences to Present at the 6th Annual Neuroscience Innovation Forum and Biotech Showcase during "J.P. Morgan Health Care Week 2023"
CAMBRIDGE, Mass.--( BUSINESS WIRE )--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the more_horizontal
By Proactive Investors
March 15, 2022
Enveric Biosciences touts the publication of four patent applications for psychedelic-inspired drug candidates
Enveric Biosciences (NASDAQ:ENVB) Inc announced that the company's first four Patent Cooperation Treaty (PCT) applications for the tryptamine family o more_horizontal
By Proactive Investors
March 1, 2022
Enveric Biosciences files portfolio of patent applications for tryptamine derivatives
Enveric Biosciences (NASDAQ:ENVB) announced that it has filed its tenth Patent Cooperation Treaty (PCT) application directed to tryptamine-based deriv more_horizontal
By Proactive Investors
March 1, 2022
Enveric Biosciences files portfolio of patent applications for tryptamine derivatives
Enveric Biosciences (NASDAQ:ENVB) announced that it has filed its tenth Patent Cooperation Treaty (PCT) application directed to tryptamine-based deriv more_horizontal
By Proactive Investors
March 1, 2022
Enveric Biosciences files portfolio of patent applications for tryptamine derivatives
Enveric Biosciences (NASDAQ:ENVB) announced that it has filed its tenth Patent Cooperation Treaty (PCT) application directed to tryptamine-based deriv more_horizontal
